The Ca2" responsiveness of vascular smooth muscle myofilaments is not unique: it is increased during neuro-humoral activation and decreased during /3-adrenergic stimulation.
Introduction
In the past, efforts to reduce the high coronary morbidity and mortality of patients with primary hypertension by antihyperten-sive treatment have failed to reduce the coronary risk in this group of patients ( 1 ) . This may reflect the fact, that the coronary disease process associated with primary hypertension is still poorly understood (2). Recent clinical (3, 4) and experimental reports using spontaneously hypertensive rats (5) have focused on the endothelial dysfunction as a possible cause of impaired coronary flow in hypertension. However, the vascular smooth muscle cells of the media may also contribute to a functionally altered regulation of coronary tone as suggested by a number of studies using isolated blood vessels obtained mainly from the mesenteric vascular bed and the aorta of genetically hypertensive rats (for reviews see references [6] [7] [8] . It has been proposed that not only structural modifications of the blood vessels (6) but also alterations in the calcium homeostasis (7) (8) (9) of the smooth muscle cells may contribute to an increased responsiveness to a number of vasoconstrictor agents. The altered calcium homeostasis would ultimately lead to an increased availability of calcium for the myofilaments (7) .
However, neurohumoral stimulation of vascular smooth muscle not only leads to an increase in the cytoplasmic Ca2+ concentration. It also increases the Ca2+ sensitivity of the myofilaments as has been demonstrated in a number of laboratories during the last decade (10) (11) (12) (13) . If the agonist induced Ca2+ sensitization of the myofilaments were augmented in hypertension this would then also contribute to an increased vasoconstrictor response. Such an augmented Ca2+ sensitization rather than alterations in the Ca2' homeostasis of the smooth muscle cells may in fact underlie the higher sensitivity to extracellular Ca2" of norepinephrine-induced contractions in intact mesenteric resistance arteries of spontaneously hypertensive rats ( 14) . We therefore tested the hypothesis that the agonist induced Ca2+ sensitization of the smooth muscle myofilaments is augmented in coronary arteries from stroke-prone spontaneously hypertensive rats (SHRSP)' as compared with their normotensive reference strain, the Wistar Kyoto (WKY) rats (15) . We chose 5-hydroxytryptamine (5-HT) as an agonist because in vivo it may be released from activated platelets (16) and it is capable of reducing coronary flow in perfused spontaneously hypertensive rat hearts (5).
Agonist-induced Ca2+ sensitization of smooth muscle myofilaments as well as the signalling cascade involved may be investigated in blood vessels permeabilized with ,6-escin (17) . In these preparations, the receptor-effector coupling is functionally intact while the ionic composition, in particular (Ca2+), may be clamped and small molecules such as nucleotides may be diffused into the smooth muscle cells. The agonist induced
Ca2" sensitization appears to be mediated by a G proteincoupled mechanism as it is mimicked by the nonhydrolyzable GTP analog, GTPyS, which permanently activates G proteins (17) (18) (19) . Downstream events may involve inhibition of myosin light chain phosphatase (20, 21 ) and activation of protein kinase C (PK-C, 22, 23) .
In this study we show that in f3-escin permeabilized coronary arteries from SHRSP and WKY rats, 5-HT increases the Ca2+ sensitivity of the myofilaments and this effect is more pronounced in the genetically hypertensive rats. The effect of 5-HT on Ca2" sensitivity of force is mimicked by GTPyS.
Again, the effect of GTPyS is larger in the coronary arteries from SHRSP. In contrast, in the absence of 5-HT or GTPyS, the Ca2+ sensitivity of the myofilaments is not different between SHRSP and WKY rats (see reference 24) . This suggests that the G protein effector coupling within the coronary artery smooth muscle cells involved in modulating Ca2" sensitivity of force production may differ between genetically hypertensive and normotensive rats. This finding points to a novel mechanism contributing to the hyperresponsiveness of coronary arteries of SHRSP which is not related to altered Ca2' homeostasis or endothelial dysfunction.
Methods
Animals. 12-14-wk-old male rats were obtained from the colony at the Pharmacology Department of the University of Heidelberg (15) . The body weight of the SHRSP rats was 236±26 g (n = 11) and that of the WKY rats 315±24 g (n = 12). Systolic blood pressure was measured before the experiments by tail plethysmography during light ether anesthesia. The 10 . PSS was gassed with 100% 02-Ring segments were mounted on a myograph (AME 801 force transducer, Horten Norway) as described previously (25, 26) . The mounting technique did not denude the vessels from the endothelium as judged by light microscopic examination of the vessels subjected to morphometry. The endothelium appeared to be functional in the intact vessels as precontraced vessels were relaxed by ADP. The ADP (10 AM) induced relaxation of vessels precontracted with 1 sM 5-HT amounted to 82±11% and 46±15% (n = 8) in WKY and SHRSP rats, respectively.
In f3-escin-permeabilized preparations, the endothelium is not functional because of the treatment with detergent and the presence of dithioerythritol in the incubation solutions (27) . The vessels were stretched to an optimum length at which the force induced by 125 mM KCl became maximum. On completion of the experiments in intact preparations, the vessels were permeabilized by treatment with /-escin according to the method of Kobayashi et al. (17) . Briefly, the coronary arteries were incubated for 20 min in Ca2+-free PSS followed by 10 min in relaxing solution. They were then incubated with 50 ,Ag/ml ,/-escin for 30 Morphological analysis was performed at a magnification of 400 using a digitizing tablet interfaced to an IBM compatible personal computer running the program Sigma Scan (Jandel Scientific GmbH, Erkrath, Germany). The length of the internal elastic lamina and the crosssectional area of the media were measured with the help of a drawing tube. The mean of three measurements of the limits of the vessels was used for further calculations. Using the method described by Furuyama (29) the thickness of the vessel wall (media thickness), the luminal diameter and the wall/lumen ratio were calculated for a standardized condition, in which the internal elastic membrane is smooth and circular. Because of oblique sections of coronary vessels in the cross section of the heart, the dimension of the in situ fixed vessel wall was determined as the ratio of surface area of the media to surface area of the vessel (= area of the lumen + area of the media) (30) .
Calculations and statistics. To make comparisons between different vessel segments possible, forces (mN) were divided by the product of the longitudinal length (J.m) and the internal circumference (C, in tim) to obtain mN per mm2 as described previously by Boels et al. (25) . The Drugs. Forskolin and 5-hydroxytryptamine hydrochloride (5-HT) were from Sigma Chemical Co., St. Louis, MO). GTP, guanosine-5'-0-(3-thiotriphosphate) (GTPyS), and guanosine-5 '-0-(2-thiodiphosphate) (GDPlS) were obtained from Boehringer Mannheim, Germany. Forskolin was dissolved in methyl sulfoxide (DMSO); the final concentration of DMSO was less than 1%, which did not affect force.
Results
Morphological characteristics of the coronary arteries. In /3-escin-permeabilized coronary arteries, fixed completely re- (Fig. 1) . In the absence of extracellular Ca2 , only small and transient contractions were induced by 5-HT (Fig. 1) . Peak force elicited by 3 ,uM 5-HT was 5±2% in WKY rats and 11±4% in SHRSP (n = 8) of that in the presence of Ca2+; the difference was not statistically significant. remained when force was expressed relative to the tension elicited by KCl (Fig. 2 B) . However, the sensitivity of the response to 4A ) which amounted to 30±7% (WKY) and 28±3% (SHRSP) of the maximal response elicited by pCa 4.8 (n = 6). 5-HT (in the continued presence of GTP) enhanced submaximal force concentration dependently at constant (Ca2+) (Fig. 4) . The Ca2+-sensitizing effect of 5-HT was reversible and was inhibited by GDPPS (Fig. 4 A) . The degree of force enhancement was significantly larger in SHRSP than in WKY rats and was shifted to lower concentrations (Fig. 4 B) . We then tested whether the Ca2+ sensitizing effect of 5- HT was mimicked by GTPyS. In these experiments, the blood vessels were activated with pCa 6.38 in the absence of GTP followed by incubation with cumulatively increasing concentrations of GTPyS. The Ca2+-activated force in WKY rats and SHRSP was respectively 28±5% and 25 ±5% of maximal force. GTPyS modified neither resting force nor maximal force but enhanced submaximal Ca2' activated force in both groups concentration dependently whereby the effect was larger in SHRSP (Fig. 5) . The threshold concentration of GTPyS was also lower in SHRSP. Interestingly, in both groups the dose response relation was biphasic, i.e., 10 MM GTPyS was less effective than 1 uM GTPyS (Fig. 5) . GTPyS nonspecifically activates all heterotrimeric G proteins, i.e., also G,. the stimulation of which leads to accumulation of cAMP through activation of adenylyl cyclase. Activation of the cAMP pathway in intact smooth muscle (33) and incubation of skinned coronary arteries with the catalytic subunit of the cAMP dependent protein kinase (34) again submaximally activated (pCa 6.38). Once force had reached a plateau, forskolin (10 MM) was added which induced a partial relaxation at constant Ca2+ (Fig. 6 ). In WKY rats the relaxing effect of forskolin on force was larger than in the SHRSP (Fig. 6 ).
Discussion
The with 5-HT but not to stimulation with KCl suggesting that the difference in the response to 5-HT was not due to a structural modification of the blood vessels. This was supported by morphometric analysis of the vessels subjected to the mechanical experiments and by an independent study of hearts fixed under retrograde constant pressure perfusion. It appears that coronary arteries from 12-14-wk-old SHRSP rats with a vessel size between 100 and 430 ,tsm have not yet developed morphologic changes. This is in accordance with findings in the superior mesenteric artery where the dimensions of the blood vessel were also not different in 10-12-wk-old SHR and WKY rats (35) whereas in peripheral mesenteric arteries structural alterations were already present in this age group (35, 36) . 5-HT has a dual action on arterial tone: in the presence of an intact endothelium, it dilates precontracted blood vessels (16, 37) ; in the absence of an intact endothelium, it acts as a vasoconstrictor (16) . Therefore it could be argued that the increased vasoconstrictor response of the intact coronary arteries of the SHRSP rats to stimulation with 5-HT might be due to a blunted endothelium-dependent vasodilatation. However, in contrast to other species, 5-HT does not release EDRF from endothelial cells of rat coronary arteries (38) . Thus, the 5-HT responses in this study appears to reflect the responses of the medial smooth muscle cells themselves.
The difference in response to 5-HT and KCl suggests that the relative contribution of pharmacomechanical and electromechanical coupling to coronary artery tone differs between SHRSP and WKY rats (see Fig. 2 B) . Pharmacomechanical coupling is associated with three events (39) : the influx of Ca2" through specific channels in the plasma membrane, release of intracellularly stored Ca2" mediated by 1P3 and an increase in the Ca2" responsiveness of the myofilaments. Alterations related to Ca2" influx and sarcoplasmic reticulum function have been reported in hypertensive rats (7, 8) . In addition, in SHRSP rats, alterations in the signalling pathways involved in modulating Ca2" sensitivity may contribute to the enhanced responsiveness to 5-HT as discussed below. (Fig. 3) . This finding is consistent with the previous reports showing that neither the pCa-force relationship nor Ca2+-induced myosin phosphorylation were altered in triton-skinned tail arteries from SHRSP (24) . It is also consistent with the finding that the pCa-force relationship is not altered in saponin-skinned spastic coronary arteries of miniature pigs, which show hyperresponsiveness to histamine (42) triton skinned aortas from rats with aldosterone-salt hypertension (43) .
A complete picture of the signalling cascade mediating agonist induced Ca2" sensitization has yet to emerge. It has been suggested that the G protein involved in Ca2" sensitization of the myofilaments may not be identical to the one which leads to the IP3 mediated Ca2" release (44) . In fact, the agonist and GTPyS induced increase in Ca2" responsiveness may be mimicked by rhoA p21 (45) and H-ras p21 (46) In this mechanism, a PK-C-dependent pathway may play an important role as it appears to make a large contribution to the activation of MAP kinase by ras p21 (49) . As PK-C appears to be involved in the agonist induced increase in Ca2+ responsiveness (22, 23) it is interesting to note that blood vessels from spontaneously hypertensive rats exhibit a greater sensitivity to stimulation with phorbol esters (54, 55) . Therefore, the augmented agonist induced Ca2" responsiveness in SHRSP may be due to alterations in the PK-C pathway. The dose response curve to GTPyS is biphasic and declines at high concentrations of GTPyS. GTPyS nonspecifically activates all G proteins in the permeabilized arteries, i.e., the one(s) involved in calcium sensitization and Gsa the activation of which leads to an increase in the cyclic AMP levels which decreases the Ca2`sensitivity of coronary arteries (34) . Thus, the force response to GTPyS is the sum of the activation of sensitizing and desensitizing pathways. It appears that at low GTPyS concentrations the sensitizing pathways prevail while at high concentrations the desensitizing pathways become more important. It was therefore of interest to see, whether the desensitizing pathways are also affected in the hypertensive animals.
Forskolin increases cAMP levels by directly activating the adenylyl cyclase and acts therefore downstream of Gsa. For- skolin relaxed f-escin-permeabilized coronary arteries at constant submaximal (Ca2+). This effect was attenuated in the genetically hypertensive rats. Therefore, the attenuated desensitization to Ca2+ may in part explain the impaired /i-adrenergic and forskolin-mediated relaxation of intact blood vessels from hypertensive animals (56) . It is at present not clear whether the diminished response to forskolin is due to a decreased level of cAMP (57, 58) . In some cases the impaired forskolin mediated relaxation appears not to involve activation mechanisms of cAMP dependent protein kinase (56) and may therefore involve events downstream of cAMP dependent protein kinase.
It will therefore be interesting to see whether the desensitizing action of the catalytic subunit of cAMP dependent protein kinase (34) is also impaired in SHRSP.
In conclusion we have shown that signalling pathways leading to the increase in Ca2" sensitivity of smooth muscle myofilaments are augmented while those leading to a decrease are diminished in coronary arteries from SHRSP. It will be interesting to see whether these alterations also occur in vascular beds involved in blood pressure regulation such as mesenteric arteries. Due to the strategies required to obtain hypertensive and normotensive control strains, a multitude of genetic differences, many more than the few which confer the blood pressure phenotype, must be expected to be present ( 15) . Future studies, therefore, have to show whether the alterations in the Ca2" sensitivity modulation are related to the pathogenesis of hypertension in this animal model and/or whether they provide a link to the coronary dysfunction of the coronary circulation seen in experimental hypertension (e.g., 5 ). This novel mechanism may then act synergistically to those related to the altered Ca2`homeostasis of the smooth muscle cells (7, 8) and to the endothelial dysfunction (5) in increasing coronary tone (5) .
